Boisen, Anja

Jacobsen, J.

Keller, Stephan Sylvest

Müllertz, A.

Nielsen, Line Hagner

Rades, Thomas

Online Research Database In Technology

                       General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.  • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal   If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.     Downloaded from orbit.dtu.dk on: Dec 20, 2017Microcontainers as an oral drug delivery system.Nielsen, Line Hagner; Keller, Stephan Sylvest; Jacobsen, J.; Rades, Thomas; Boisen, Anja; Müllertz, A.Publication date:2014Document VersionPeer reviewed versionLink back to DTU OrbitCitation (APA):Nielsen, L. H., Keller, S. S., Jacobsen, J., Rades, T., Boisen, A., & Müllertz, A. (2014). Microcontainers as anoral drug delivery system.. Abstract from Globalization of Pharmaceutics Education Network biennial meeting,Helsinki, Finland.Microcontainers as an oral drug delivery system Line Hagner Nielsena,b, Stephan Sylvest Kellerb, Jette Jacobsena, Thomas Radesa, Anja Boisenb, Anette Müllertza,c aDepartment of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark bDepartment of Micro- and Nanotechnology, Technical University of Denmark, Kongens Lyngby, Denmark cBioneer:FARMA, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark  Objective. The purpose of this study was to evaluate microcontainers in vitro and in vivo as an innovative oral drug delivery system for the poorly water-soluble drug, furosemide. Methods. Microcontainers, with an inner diameter of 223 µm, were fabricated in SU-8 through two steps of photolithography. The microcontainers were filled with amorphous sodium salt of furosemide (prepared by spray drying). Subsequently, a 10 µm layer of Eudragit® L100 was spray coated on the cavity of the drug-filled microcontainers. The release of the drug from the microcontainers was evaluated in a biorelevant gastric medium (pH 1.6) and a biorelevant intestinal medium at pH 6.5. The intestinal permeability of the amorphous furosemide salt loaded into the microcontainers was evaluated using a Caco-2 cell model. Furthermore, drug-filled and Eudragit-coated microcontainers were dosed orally to rats and blood samples were taken over 24 h.   Results. The release experiments revealed that the Eudragit® layer prevented drug release in the gastric medium, while an immediate release of the amorphous furosemide salt was seen in the intestinal medium. The Caco-2 cell studies showed a fast permeability of the amorphous furosemide salt with no significant differences between the microcontainers (Papp 1.79·10-5 ±0.068·10-5 cm/s, mean±SD, n=11) and powder of amorphous furosemide salt (Papp 1.62·10-5 ±1.04·10-5 cm/s, mean±SD, n=11). The rat study demonstrated that the amorphous furosemide salt dosed in microcontainers showed an oral relative bioavailability of 220.2±43.2% (mean±SEM, n=6) compared to amorphous furosemide salt filled into capsules and coated with Eudragit® L100.   Conclusions. Microcontainers show considerable potential as a future oral drug delivery system.  

Microcontainers as an oral drug delivery system.

http://orbit.dtu.dk/ws/files/97132008/Nielsen_Abstract.pdf

Microcontainers as an oral drug delivery system.

Abstract

Similar works

Full text

Available Versions

Online Research Database In Technology